25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Suven Pharmaceuticals Ltd
Buy, Hold or Sell?

Let's analyze Suven Pharmaceuticals Ltd together

I guess you are interested in Suven Pharmaceuticals Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Suven Pharmaceuticals Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Suven Pharmaceuticals Ltd

I send you an email if I find something interesting about Suven Pharmaceuticals Ltd.

1. Quick Overview

1.1. Quick analysis of Suven Pharmaceuticals Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Suven Pharmaceuticals Ltd? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
80.0%

What is your share worth?

Current worth
INR80.56
Expected worth in 1 year
INR130.13
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR49.57
Return On Investment
3.8%

For what price can you sell your share?

Current Price per Share
INR1,303.85
Expected price per share
INR1,135 - INR1,359
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Suven Pharmaceuticals Ltd (5 min.)




Live pricePrice per Share (EOD)
INR1,303.85
Intrinsic Value Per Share
INR86.54 - INR101.19
Total Value Per Share
INR167.09 - INR181.74

2.2. Growth of Suven Pharmaceuticals Ltd (5 min.)




Is Suven Pharmaceuticals Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$241.9m$204.7m$37.2m15.4%

How much money is Suven Pharmaceuticals Ltd making?

Current yearPrevious yearGrowGrow %
Making money$35.4m$48.5m-$13m-37.0%
Net Profit Margin29.0%30.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Suven Pharmaceuticals Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Suven Pharmaceuticals Ltd?

Welcome investor! Suven Pharmaceuticals Ltd's management wants to use your money to grow the business. In return you get a share of Suven Pharmaceuticals Ltd.

First you should know what it really means to hold a share of Suven Pharmaceuticals Ltd. And how you can make/lose money.

Speculation

The Price per Share of Suven Pharmaceuticals Ltd is INR1,304. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Suven Pharmaceuticals Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Suven Pharmaceuticals Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR80.56. Based on the TTM, the Book Value Change Per Share is INR12.39 per quarter. Based on the YOY, the Book Value Change Per Share is INR8.17 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Suven Pharmaceuticals Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.140.0%0.140.0%0.190.0%0.170.0%0.170.0%
Usd Book Value Change Per Share0.150.0%0.150.0%0.100.0%0.190.0%0.190.0%
Usd Dividend Per Share0.000.0%0.000.0%0.090.0%0.030.0%0.030.0%
Usd Total Gains Per Share0.150.0%0.150.0%0.190.0%0.220.0%0.220.0%
Usd Price Per Share7.98-7.98-5.58-5.82-5.82-
Price to Earnings Ratio57.36-57.36-29.26-34.45-34.45-
Price-to-Total Gains Ratio54.60-54.60-29.23-32.83-32.83-
Price to Book Ratio8.40-8.40-6.93-8.48-8.48-
Price-to-Total Gains Ratio54.60-54.60-29.23-32.83-32.83-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share15.38543
Number of shares64
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.03
Usd Book Value Change Per Share0.150.19
Usd Total Gains Per Share0.150.22
Gains per Quarter (64 shares)9.3614.02
Gains per Year (64 shares)37.4456.07
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10372774946
2075641597102
3011210122146158
4015013830195214
5018717537243270
6022521244292326
7026224952341382
8029928659389438
9033732367438494
10037436074487550

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%
Dividend per Share0.00.01.00.0%2.00.01.066.7%4.00.01.080.0%4.00.01.080.0%4.00.01.080.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Suven Pharmaceuticals Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--12.39312.3930%8.171+52%16.111-23%16.111-23%
Book Value Per Share--80.55680.5560%68.163+18%57.656+40%57.656+40%
Current Ratio--11.81711.8170%6.368+86%5.615+110%5.615+110%
Debt To Asset Ratio--0.0900.0900%0.117-23%0.170-47%0.170-47%
Debt To Equity Ratio--0.0990.0990%0.133-25%0.213-54%0.213-54%
Dividend Per Share----0%8.000-100%2.450-100%2.450-100%
Eps--11.79611.7960%16.157-27%14.493-19%14.493-19%
Free Cash Flow Per Share--12.04812.0480%6.487+86%10.337+17%10.337+17%
Free Cash Flow To Equity Per Share--12.04812.0480%6.487+86%8.572+41%8.572+41%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--101.188--------
Intrinsic Value_10Y_min--86.537--------
Intrinsic Value_1Y_max--9.671--------
Intrinsic Value_1Y_min--9.398--------
Intrinsic Value_3Y_max--29.416--------
Intrinsic Value_3Y_min--27.775--------
Intrinsic Value_5Y_max--49.590--------
Intrinsic Value_5Y_min--45.505--------
Market Cap331914564819.200+48%172238673587.200172238673587.2000%120332871718.400+43%125454719357.440+37%125454719357.440+37%
Net Profit Margin--0.2900.2900%0.307-6%0.342-15%0.342-15%
Operating Margin----0%0.387-100%0.334-100%0.334-100%
Operating Ratio--1.0901.0900%1.050+4%1.023+7%1.023+7%
Pb Ratio16.186+48%8.3998.3990%6.935+21%8.477-1%8.477-1%
Pe Ratio110.535+48%57.35957.3590%29.257+96%34.453+66%34.453+66%
Price Per Share1303.850+48%676.600676.6000%472.700+43%492.820+37%492.820+37%
Price To Free Cash Flow Ratio108.223+48%56.15956.1590%72.867-23%50.645+11%50.645+11%
Price To Total Gains Ratio105.210+48%54.59654.5960%29.231+87%32.832+66%32.832+66%
Quick Ratio--8.4908.4900%3.337+154%3.453+146%3.453+146%
Return On Assets--0.1330.1330%0.209-36%0.221-40%0.221-40%
Return On Equity--0.1460.1460%0.237-38%0.273-46%0.273-46%
Total Gains Per Share--12.39312.3930%16.171-23%18.561-33%18.561-33%
Usd Book Value--241978293.000241978293.0000%204751747.400+18%173190941.120+40%173190941.120+40%
Usd Book Value Change Per Share--0.1460.1460%0.096+52%0.190-23%0.190-23%
Usd Book Value Per Share--0.9510.9510%0.804+18%0.680+40%0.680+40%
Usd Dividend Per Share----0%0.094-100%0.029-100%0.029-100%
Usd Eps--0.1390.1390%0.191-27%0.171-19%0.171-19%
Usd Free Cash Flow--36190151.60036190151.6000%19486626.200+86%31052356.080+17%31052356.080+17%
Usd Free Cash Flow Per Share--0.1420.1420%0.077+86%0.122+17%0.122+17%
Usd Free Cash Flow To Equity Per Share--0.1420.1420%0.077+86%0.101+41%0.101+41%
Usd Market Cap3916591864.867+48%2032416348.3292032416348.3290%1419927886.277+43%1480365688.418+37%1480365688.418+37%
Usd Price Per Share15.385+48%7.9847.9840%5.578+43%5.815+37%5.815+37%
Usd Profit--35433099.00035433099.0000%48532255.400-27%43535373.120-19%43535373.120-19%
Usd Revenue--122229887.000122229887.0000%158158798.400-23%128687429.920-5%128687429.920-5%
Usd Total Gains Per Share--0.1460.1460%0.191-23%0.219-33%0.219-33%
 EOD+4 -4MRQTTM+0 -0YOY+19 -165Y+17 -1810Y+17 -18

3.3 Fundamental Score

Let's check the fundamental score of Suven Pharmaceuticals Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15110.535
Price to Book Ratio (EOD)Between0-116.186
Net Profit Margin (MRQ)Greater than00.290
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than18.490
Current Ratio (MRQ)Greater than111.817
Debt to Asset Ratio (MRQ)Less than10.090
Debt to Equity Ratio (MRQ)Less than10.099
Return on Equity (MRQ)Greater than0.150.146
Return on Assets (MRQ)Greater than0.050.133
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of Suven Pharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.505
Ma 20Greater thanMa 501,285.018
Ma 50Greater thanMa 1001,246.495
Ma 100Greater thanMa 2001,128.212
OpenGreater thanClose1,274.950
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Suven Pharmaceuticals Ltd

Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was founded in 1989 and is based in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Berhyanda Limited.

Fundamental data was last updated by Penke on 2024-11-17 16:10:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is overpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Suven Pharmaceuticals Ltd earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Suven Pharmaceuticals Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 29.0% means that ₹0.29 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Suven Pharmaceuticals Ltd:

  • The MRQ is 29.0%. The company is making a huge profit. +2
  • The TTM is 29.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ29.0%TTM29.0%0.0%
TTM29.0%YOY30.7%-1.7%
TTM29.0%5Y34.2%-5.2%
5Y34.2%10Y34.2%0.0%
4.3.1.2. Return on Assets

Shows how efficient Suven Pharmaceuticals Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Suven Pharmaceuticals Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 13.3% Return on Assets means that Suven Pharmaceuticals Ltd generated ₹0.13 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Suven Pharmaceuticals Ltd:

  • The MRQ is 13.3%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 13.3%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ13.3%TTM13.3%0.0%
TTM13.3%YOY20.9%-7.6%
TTM13.3%5Y22.1%-8.8%
5Y22.1%10Y22.1%0.0%
4.3.1.3. Return on Equity

Shows how efficient Suven Pharmaceuticals Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Suven Pharmaceuticals Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 14.6% Return on Equity means Suven Pharmaceuticals Ltd generated ₹0.15 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Suven Pharmaceuticals Ltd:

  • The MRQ is 14.6%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 14.6%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ14.6%TTM14.6%0.0%
TTM14.6%YOY23.7%-9.1%
TTM14.6%5Y27.3%-12.6%
5Y27.3%10Y27.3%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Suven Pharmaceuticals Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Suven Pharmaceuticals Ltd is operating .

  • Measures how much profit Suven Pharmaceuticals Ltd makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Suven Pharmaceuticals Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Suven Pharmaceuticals Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY38.7%-38.7%
TTM-5Y33.4%-33.4%
5Y33.4%10Y33.4%0.0%
4.3.2.2. Operating Ratio

Measures how efficient Suven Pharmaceuticals Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.09 means that the operating costs are ₹1.09 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Suven Pharmaceuticals Ltd:

  • The MRQ is 1.090. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.090. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.090TTM1.0900.000
TTM1.090YOY1.050+0.041
TTM1.0905Y1.023+0.068
5Y1.02310Y1.0230.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Suven Pharmaceuticals Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Suven Pharmaceuticals Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 11.82 means the company has ₹11.82 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Suven Pharmaceuticals Ltd:

  • The MRQ is 11.817. The company is very able to pay all its short-term debts. +2
  • The TTM is 11.817. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ11.817TTM11.8170.000
TTM11.817YOY6.368+5.449
TTM11.8175Y5.615+6.202
5Y5.61510Y5.6150.000
4.4.3.2. Quick Ratio

Measures if Suven Pharmaceuticals Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Suven Pharmaceuticals Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 8.49 means the company can pay off ₹8.49 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Suven Pharmaceuticals Ltd:

  • The MRQ is 8.490. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 8.490. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.490TTM8.4900.000
TTM8.490YOY3.337+5.153
TTM8.4905Y3.453+5.037
5Y3.45310Y3.4530.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Suven Pharmaceuticals Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Suven Pharmaceuticals Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Suven Pharmaceuticals Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.09 means that Suven Pharmaceuticals Ltd assets are financed with 9.0% credit (debt) and the remaining percentage (100% - 9.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Suven Pharmaceuticals Ltd:

  • The MRQ is 0.090. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.090. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.090TTM0.0900.000
TTM0.090YOY0.117-0.027
TTM0.0905Y0.170-0.080
5Y0.17010Y0.1700.000
4.5.4.2. Debt to Equity Ratio

Measures if Suven Pharmaceuticals Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Suven Pharmaceuticals Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 9.9% means that company has ₹0.10 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Suven Pharmaceuticals Ltd:

  • The MRQ is 0.099. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.099. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.099TTM0.0990.000
TTM0.099YOY0.133-0.034
TTM0.0995Y0.213-0.114
5Y0.21310Y0.2130.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Suven Pharmaceuticals Ltd generates.

  • Above 15 is considered overpriced but always compare Suven Pharmaceuticals Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 57.36 means the investor is paying ₹57.36 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Suven Pharmaceuticals Ltd:

  • The EOD is 110.535. Based on the earnings, the company is expensive. -2
  • The MRQ is 57.359. Based on the earnings, the company is expensive. -2
  • The TTM is 57.359. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD110.535MRQ57.359+53.176
MRQ57.359TTM57.3590.000
TTM57.359YOY29.257+28.102
TTM57.3595Y34.453+22.907
5Y34.45310Y34.4530.000
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Suven Pharmaceuticals Ltd:

  • The EOD is 108.223. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 56.159. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 56.159. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD108.223MRQ56.159+52.063
MRQ56.159TTM56.1590.000
TTM56.159YOY72.867-16.707
TTM56.1595Y50.645+5.514
5Y50.64510Y50.6450.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Suven Pharmaceuticals Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 8.40 means the investor is paying ₹8.40 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Suven Pharmaceuticals Ltd:

  • The EOD is 16.186. Based on the equity, the company is expensive. -2
  • The MRQ is 8.399. Based on the equity, the company is overpriced. -1
  • The TTM is 8.399. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD16.186MRQ8.399+7.787
MRQ8.399TTM8.3990.000
TTM8.399YOY6.935+1.464
TTM8.3995Y8.477-0.078
5Y8.47710Y8.4770.000
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets22,540,865
Total Liabilities2,034,230
Total Stockholder Equity20,506,634
 As reported
Total Liabilities 2,034,230
Total Stockholder Equity+ 20,506,634
Total Assets = 22,540,865

Assets

Total Assets22,540,865
Total Current Assets12,631,863
Long-term Assets9,909,002
Total Current Assets
Cash And Cash Equivalents 472,312
Short-term Investments 7,738,955
Net Receivables 1,336,592
Inventory 2,311,956
Other Current Assets 1
Total Current Assets  (as reported)12,631,863
Total Current Assets  (calculated)11,859,816
+/- 772,047
Long-term Assets
Property Plant Equipment 7,888,085
Goodwill 602,583
Intangible Assets 16,674
Long-term Assets  (as reported)9,909,002
Long-term Assets  (calculated)8,507,342
+/- 1,401,660

Liabilities & Shareholders' Equity

Total Current Liabilities1,068,957
Long-term Liabilities965,273
Total Stockholder Equity20,506,634
Total Current Liabilities
Short Long Term Debt 385,753
Accounts payable 423,574
Other Current Liabilities 65,086
Total Current Liabilities  (as reported)1,068,957
Total Current Liabilities  (calculated)874,413
+/- 194,544
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt264,211
Long-term Liabilities Other 1
Long-term Liabilities  (as reported)965,273
Long-term Liabilities  (calculated)264,212
+/- 701,061
Total Stockholder Equity
Retained Earnings 17,651,179
Total Stockholder Equity (as reported)20,506,634
Total Stockholder Equity (calculated)17,651,179
+/- 2,855,455
Other
Capital Stock254,565
Common Stock Shares Outstanding 254,565
Net Invested Capital 20,892,387
Net Working Capital 11,562,906
Property Plant and Equipment Gross 10,409,352



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-31
> Total Assets 
11,728,105
14,744,651
18,295,873
19,657,438
22,540,865
22,540,86519,657,43818,295,87314,744,65111,728,105
   > Total Current Assets 
3,916,477
5,647,852
11,279,320
10,110,458
12,631,863
12,631,86310,110,45811,279,3205,647,8523,916,477
       Cash And Cash Equivalents 
116,953
71,822
445,638
648,028
472,312
472,312648,028445,63871,822116,953
       Short-term Investments 
306,761
1,805,938
4,812,224
4,189,350
7,738,955
7,738,9554,189,3504,812,2241,805,938306,761
       Net Receivables 
1,171,958
1,023,821
2,363,723
1,109,393
1,336,592
1,336,5921,109,3932,363,7231,023,8211,171,958
       Inventory 
1,863,132
2,127,191
3,000,167
3,128,104
2,311,956
2,311,9563,128,1043,000,1672,127,1911,863,132
       Other Current Assets 
58,281
56,716
111,668
3
1
13111,66856,71658,281
   > Long-term Assets 
7,811,638
9,096,799
7,016,553
9,546,980
9,909,002
9,909,0029,546,9807,016,5539,096,7997,811,638
       Property Plant Equipment 
4,556,530
5,348,896
5,619,513
7,694,770
7,888,085
7,888,0857,694,7705,619,5135,348,8964,556,530
       Goodwill 
0
0
0
602,583
602,583
602,583602,583000
       Intangible Assets 
27,960
25,904
22,364
19,320
16,674
16,67419,32022,36425,90427,960
       Other Assets 
152,593
110,158
203,710
0
0
00203,710110,158152,593
> Total Liabilities 
3,280,478
2,936,568
3,024,069
2,305,595
2,034,230
2,034,2302,305,5953,024,0692,936,5683,280,478
   > Total Current Liabilities 
2,003,752
2,197,480
2,102,940
1,587,659
1,068,957
1,068,9571,587,6592,102,9402,197,4802,003,752
       Short Long Term Debt 
940,380
1,056,376
671,330
645,978
385,753
385,753645,978671,3301,056,376940,380
       Accounts payable 
710,557
829,313
1,059,007
700,916
423,574
423,574700,9161,059,007829,313710,557
       Other Current Liabilities 
212,702
103,082
95,693
21,450
65,086
65,08621,45095,693103,082212,702
   > Long-term Liabilities 
1,276,763
739,088
921,129
717,936
965,273
965,273717,936921,129739,0881,276,763
       Long term Debt 
912,525
355,909
284,404
45,642
0
045,642284,404355,909912,525
       Capital Lease Obligations Min Short Term Debt
9,160
18,072
15,538
11,788
264,211
264,21111,78815,53818,0729,160
       Other Liabilities 
359,118
375,889
632,096
0
0
00632,096375,889359,118
       Long-term Liabilities Other 
1
100
0
0
1
1001001
> Total Stockholder Equity
8,447,627
11,808,083
15,271,803
17,351,843
20,506,634
20,506,63417,351,84315,271,80311,808,0838,447,627
   Common Stock
127,282
254,565
254,565
0
0
00254,565254,565127,282
   Retained Earnings 
6,947,210
10,307,693
13,819,853
14,651,606
17,651,179
17,651,17914,651,60613,819,85310,307,6936,947,210
   Capital Surplus 00000
   Treasury Stock00000
   Other Stockholders Equity 
150,114
150,087
101,648
0
0
00101,648150,087150,114



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue10,358,465
Cost of Revenue-4,485,106
Gross Profit5,873,3595,873,359
 
Operating Income (+$)
Gross Profit5,873,359
Operating Expense-6,810,639
Operating Income3,547,826-937,280
 
Operating Expense (+$)
Research Development0
Selling General Administrative295,199
Selling And Marketing Expenses0
Operating Expense6,810,639295,199
 
Net Interest Income (+$)
Interest Income20,154
Interest Expense-74,511
Other Finance Cost-0
Net Interest Income-54,357
 
Pretax Income (+$)
Operating Income3,547,826
Net Interest Income-54,357
Other Non-Operating Income Expenses0
Income Before Tax (EBT)4,056,7153,547,826
EBIT - interestExpense = -74,511
3,002,805
3,077,316
Interest Expense74,511
Earnings Before Interest and Taxes (EBIT)04,131,226
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax4,056,715
Tax Provision-1,053,911
Net Income From Continuing Ops3,002,8043,002,804
Net Income3,002,805
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net054,357
 

Technical Analysis of Suven Pharmaceuticals Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Suven Pharmaceuticals Ltd. The general trend of Suven Pharmaceuticals Ltd is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Suven Pharmaceuticals Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Suven Pharmaceuticals Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1,359.

The bearish price targets are: 1,197 > 1,141 > 1,135.

Tweet this
Suven Pharmaceuticals Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Suven Pharmaceuticals Ltd. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Suven Pharmaceuticals Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Suven Pharmaceuticals Ltd. The current macd is 10.75.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Suven Pharmaceuticals Ltd price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Suven Pharmaceuticals Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Suven Pharmaceuticals Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Suven Pharmaceuticals Ltd Daily Moving Average Convergence/Divergence (MACD) ChartSuven Pharmaceuticals Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Suven Pharmaceuticals Ltd. The current adx is 17.41.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Suven Pharmaceuticals Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Suven Pharmaceuticals Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Suven Pharmaceuticals Ltd. The current sar is 1,220.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Suven Pharmaceuticals Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Suven Pharmaceuticals Ltd. The current rsi is 57.50. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Suven Pharmaceuticals Ltd Daily Relative Strength Index (RSI) ChartSuven Pharmaceuticals Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Suven Pharmaceuticals Ltd. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Suven Pharmaceuticals Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Suven Pharmaceuticals Ltd Daily Stochastic Oscillator ChartSuven Pharmaceuticals Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Suven Pharmaceuticals Ltd. The current cci is 51.76.

Suven Pharmaceuticals Ltd Daily Commodity Channel Index (CCI) ChartSuven Pharmaceuticals Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Suven Pharmaceuticals Ltd. The current cmo is 18.01.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Suven Pharmaceuticals Ltd Daily Chande Momentum Oscillator (CMO) ChartSuven Pharmaceuticals Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Suven Pharmaceuticals Ltd. The current willr is -21.86353632.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Suven Pharmaceuticals Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Suven Pharmaceuticals Ltd Daily Williams %R ChartSuven Pharmaceuticals Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Suven Pharmaceuticals Ltd.

Suven Pharmaceuticals Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Suven Pharmaceuticals Ltd. The current atr is 41.78.

Suven Pharmaceuticals Ltd Daily Average True Range (ATR) ChartSuven Pharmaceuticals Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Suven Pharmaceuticals Ltd. The current obv is 3,578,796.

Suven Pharmaceuticals Ltd Daily On-Balance Volume (OBV) ChartSuven Pharmaceuticals Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Suven Pharmaceuticals Ltd. The current mfi is 70.50.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Suven Pharmaceuticals Ltd Daily Money Flow Index (MFI) ChartSuven Pharmaceuticals Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Suven Pharmaceuticals Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-31STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-01MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-02STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-03MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-05BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-12MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-31CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Suven Pharmaceuticals Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Suven Pharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.505
Ma 20Greater thanMa 501,285.018
Ma 50Greater thanMa 1001,246.495
Ma 100Greater thanMa 2001,128.212
OpenGreater thanClose1,274.950
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Suven Pharmaceuticals Ltd with someone you think should read this too:
  • Are you bullish or bearish on Suven Pharmaceuticals Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Suven Pharmaceuticals Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Suven Pharmaceuticals Ltd

I send you an email if I find something interesting about Suven Pharmaceuticals Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Suven Pharmaceuticals Ltd.

Receive notifications about Suven Pharmaceuticals Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.